JP2023505708A5 - - Google Patents
Info
- Publication number
- JP2023505708A5 JP2023505708A5 JP2022535591A JP2022535591A JP2023505708A5 JP 2023505708 A5 JP2023505708 A5 JP 2023505708A5 JP 2022535591 A JP2022535591 A JP 2022535591A JP 2022535591 A JP2022535591 A JP 2022535591A JP 2023505708 A5 JP2023505708 A5 JP 2023505708A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- represented
- variable region
- chain variable
- light chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911273041.7 | 2019-12-12 | ||
| CN201911273041 | 2019-12-12 | ||
| CN202011060513 | 2020-09-30 | ||
| CN202011060513.3 | 2020-09-30 | ||
| PCT/CN2020/135680 WO2021115426A1 (zh) | 2019-12-12 | 2020-12-11 | 抗密蛋白抗体药物偶联物及其医药用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023505708A JP2023505708A (ja) | 2023-02-10 |
| JP2023505708A5 true JP2023505708A5 (cg-RX-API-DMAC7.html) | 2023-12-18 |
| JP7720305B2 JP7720305B2 (ja) | 2025-08-07 |
Family
ID=76329625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022535591A Active JP7720305B2 (ja) | 2019-12-12 | 2020-12-11 | 抗クローディン抗体薬物複合体及びその医薬用途 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230054458A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4074345A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7720305B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220113728A (cg-RX-API-DMAC7.html) |
| CN (2) | CN118403182A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020402006A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022011032A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3162754A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022006893A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021115426A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021011489A (es) * | 2019-04-01 | 2021-10-22 | Jiangsu Hengrui Medicine Co | Anticuerpo anti-claudina 18.2 y utilizacion del mismo. |
| US20230101735A1 (en) * | 2020-01-22 | 2023-03-30 | Jiangsu Hengrui Medicine Co., Ltd. | Anti-trop-2 antidody-exatecan analog conjugate and medical use thereof |
| JP7821733B2 (ja) * | 2020-01-22 | 2026-02-27 | 上海森輝医薬有限公司 | エリブリン誘導体の薬物複合体、その調製方法及びその医薬的応用 |
| CA3175048A1 (en) * | 2020-03-25 | 2021-09-30 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Preparation method for antibody medicament conjugate |
| WO2022078259A1 (zh) * | 2020-10-12 | 2022-04-21 | 四川百利药业有限责任公司 | 一种氘代的喜树碱衍生物及其抗体药物偶联物 |
| US11806405B1 (en) | 2021-07-19 | 2023-11-07 | Zeno Management, Inc. | Immunoconjugates and methods |
| CA3224492A1 (en) | 2021-07-19 | 2023-01-26 | Xiaojun Han | Immunoconjugates and methods |
| EP4410307A4 (en) | 2021-09-30 | 2026-05-06 | Jiangsu Hengrui Pharmaceuticals Co Ltd | PYRROLO BENZODIAZEPINE DERIVATIVE AND CONJUGATE, PROCESS FOR THEIR PREPARATION AND USE |
| CN118139876A (zh) * | 2021-10-19 | 2024-06-04 | 博奥信生物技术(南京)有限公司 | 结合cldn18.2的抗体及其用途 |
| JP7767613B2 (ja) | 2021-11-15 | 2025-11-11 | システィミューン,インコーポレイテッド | 二重特異性抗体-カンプトテシン薬物複合体及びその製薬的使用 |
| US11814394B2 (en) | 2021-11-16 | 2023-11-14 | Genequantum Healthcare (Suzhou) Co., Ltd. | Exatecan derivatives, linker-payloads, and conjugates and thereof |
| AU2022416272A1 (en) * | 2021-12-17 | 2024-07-18 | Fortvita Biologics (Singapore) Pte. Ltd. | Antibody-drug conjugate targeting claudin18.2 |
| WO2024012566A2 (en) | 2022-07-15 | 2024-01-18 | Genequantum Healthcare (Suzhou) Co., Ltd. | Antibody, linkers, payload, conjugates and applications thereof |
| CN120225528A (zh) * | 2022-09-02 | 2025-06-27 | 默沙东有限责任公司 | 依喜替康衍生的拓扑异构酶-1抑制剂药物组合物及其用途 |
| AU2024380559A1 (en) | 2023-11-17 | 2026-06-04 | Mersana Therapeutics, Inc. | Treatment of cancer using b7-h4-targeted antibody-drug conjugates |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| US6504029B1 (en) | 1995-04-10 | 2003-01-07 | Daiichi Pharmaceutical Co., Ltd. | Condensed-hexacyclic compounds and a process therefor |
| WO2003000657A1 (en) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Diamine derivatives |
| ES2605443T3 (es) | 2003-11-06 | 2017-03-14 | Seattle Genetics, Inc. | Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia |
| JP2015506349A (ja) | 2011-12-21 | 2015-03-02 | アルデリックス, インコーポレイテッド | 非全身性tgr5アゴニスト |
| CN104168899B (zh) | 2012-01-13 | 2017-04-05 | 通用医疗公司 | 麻醉剂化合物及其相关的使用方法 |
| US10195288B2 (en) | 2012-10-11 | 2019-02-05 | Daiichi Sankyo Company, Limited | Antibody-drug conjugate |
| SG11201603960XA (en) | 2014-01-31 | 2016-07-28 | Daiichi Sankyo Co Ltd | Anti-her2 antibody-drug conjugate |
| WO2016165762A1 (en) | 2015-04-15 | 2016-10-20 | Ganymed Pharmaceuticals Ag | Drug conjugates comprising antibodies against claudin 18.2 |
| CN108101825B (zh) * | 2016-11-25 | 2022-02-22 | 迈威(上海)生物科技股份有限公司 | 用于抗体-药物偶联的双取代马来酰胺类连接子及其制备方法和用途 |
| CN109106951A (zh) * | 2017-08-18 | 2019-01-01 | 四川百利药业有限责任公司 | 一种喜树碱-抗体偶联物 |
| EP3794042B1 (en) | 2018-05-18 | 2024-03-27 | Daiichi Sankyo Co., Ltd. | Anti-muc1- exatecan antibody-drug conjugate |
| EP3808376A4 (en) * | 2018-06-17 | 2021-09-01 | L&L Biopharma Co., Ltd. | CLDN18.2 ANTIBODY, BISPECIFIC ANTIBODY, ADC AND CAR, AND APPLICATIONS THEREOF |
| CN111110862A (zh) * | 2018-11-01 | 2020-05-08 | 上海健信生物医药科技有限公司 | 抗cldn18.2抗体的药物偶联体及其制备方法和用途 |
| UA130338C2 (uk) * | 2018-09-26 | 2026-01-28 | Джянгсу Хенгруй Медісін Ко., Лтд. | Кон'югат ліганд-лікарський засіб аналога ексатекану, спосіб його отримання та його застосування |
| JP7408646B2 (ja) * | 2018-09-30 | 2024-01-05 | ジエンス ハンソー ファーマスーティカル グループ カンパニー リミテッド | 抗-b7h3抗体-エキサテカンアナログコンジュゲート及びその医薬用途 |
| CN109762067B (zh) * | 2019-01-17 | 2020-02-28 | 北京天广实生物技术股份有限公司 | 结合人Claudin 18.2的抗体及其用途 |
| MX2021011489A (es) * | 2019-04-01 | 2021-10-22 | Jiangsu Hengrui Medicine Co | Anticuerpo anti-claudina 18.2 y utilizacion del mismo. |
| CN111689980A (zh) * | 2019-05-26 | 2020-09-22 | 四川百利药业有限责任公司 | 一种喜树碱药物及其抗体偶联物 |
| AU2020288275A1 (en) * | 2019-06-06 | 2022-02-03 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Anti-B7-H4 antibody–drug conjugate and medicinal use thereof |
| WO2020259258A1 (zh) * | 2019-06-28 | 2020-12-30 | 上海复旦张江生物医药股份有限公司 | 一种抗体偶联药物、其中间体、制备方法及应用 |
| AU2021354827A1 (en) * | 2020-09-30 | 2023-06-01 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Pharmaceutical composition comprising antibody-drug conjugate, and use of pharmaceutical composition |
-
2020
- 2020-12-11 AU AU2020402006A patent/AU2020402006A1/en active Pending
- 2020-12-11 WO PCT/CN2020/135680 patent/WO2021115426A1/zh not_active Ceased
- 2020-12-11 CN CN202410509070.3A patent/CN118403182A/zh active Pending
- 2020-12-11 CA CA3162754A patent/CA3162754A1/en active Pending
- 2020-12-11 CN CN202080077964.XA patent/CN114650845B/zh active Active
- 2020-12-11 BR BR112022011032A patent/BR112022011032A2/pt unknown
- 2020-12-11 EP EP20898395.7A patent/EP4074345A4/en active Pending
- 2020-12-11 KR KR1020227022162A patent/KR20220113728A/ko active Pending
- 2020-12-11 MX MX2022006893A patent/MX2022006893A/es unknown
- 2020-12-11 JP JP2022535591A patent/JP7720305B2/ja active Active
- 2020-12-11 US US17/782,980 patent/US20230054458A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023510905A5 (cg-RX-API-DMAC7.html) | ||
| TWI869913B (zh) | 吡啶并[4,3-d]嘧啶化合物 | |
| CN111377871B (zh) | 一种fak抑制剂及其联合用药物 | |
| JP2023506805A5 (cg-RX-API-DMAC7.html) | ||
| WO2024218686A1 (en) | Pyrido[4,3-d]pyrimidine compounds | |
| ES2779152T3 (es) | Derivados de (2-(5-isoindolin-2-il)pirimidin-4-il)-amina como inhibidores de Rho-quinasa para tratar enfermedades autoinmunes | |
| CA3168654A1 (en) | Drug conjugate of eribulin derivative, preparation method therefor and application thereof in medicine | |
| BR112021004829A2 (pt) | conjugado de anticorpo anti-b7h3-análogo de exatecano e uso medicinal do mesmo | |
| JP2023519261A5 (cg-RX-API-DMAC7.html) | ||
| TW202144015A (zh) | B7h3抗體-依喜替康類似物偶聯物及其醫藥用途 | |
| JP2022511351A5 (cg-RX-API-DMAC7.html) | ||
| EP3678700B1 (en) | Compounds for reducing the viscosity of biological formulations | |
| TW202108181A (zh) | 抗trop2抗體及其生產方法、及抗trop2抗體-藥物結合物 | |
| KR20250100539A (ko) | 피리도[4,3-d]피리미딘 화합물 | |
| CN116096896A (zh) | 一种含抗体药物偶联物的药物组合物及其用途 | |
| CN111617078B (zh) | 用于疾病治疗和/或预防的药物组合物、方法及其用途 | |
| CA2944255C (en) | New derivatives of cephalosporin for treating cancer | |
| KR20220167275A (ko) | 암 치료 방법 | |
| JP2024545138A (ja) | 親和性が改善された抗体薬物複合体、その調製法、及びその応用 | |
| JP2024536798A5 (cg-RX-API-DMAC7.html) | ||
| RU2022125170A (ru) | Конъюгат антитела против PSMA и аналога эксатекана и его медицинское применение | |
| CN120554370A (zh) | 一种抗体-药物偶联物及其制备方法和用途 | |
| HK40117290A (en) | Pyrido[4,3-d]pyrimidine compounds | |
| WO2025231223A1 (en) | Wee1 inhibitor combination therapy | |
| WO2023044016A2 (en) | Antibody immune-stimulant conjugates and use thereof |